1、张波, 李大魁. 超药品说明书用药参考(第2版)[M]. 北京: 人民卫生出版社, 2013: 273-296.
ZHANG Bo, LI Dakui. Reference for use of super drug instructions (2nd edition)[M]. Beijing: People’s Health Publishing House, 2013: 273-296.张波, 李大魁. 超药品说明书用药参考(第2版)[M]. 北京: 人民卫生出版社, 2013: 273-296.
ZHANG Bo, LI Dakui. Reference for use of super drug instructions (2nd edition)[M]. Beijing: People’s Health Publishing House, 2013: 273-296.
2、中国医药教育协会感染疾病专业委员会, 中华结核和呼吸杂志编辑委员会, 中国药学会药物临床评价研究专业委员会. 抗菌药物超说明书用法专家共识[ J]. 中华结核和呼吸杂志, 2015, 38(6): 410-444.
Infectious Diseases Society of China, Chinese Journal of Tuberculosis and Respiratory Diseases, Drug Clinical Evaluation Research Committee of Chinese Pharmaceutical Association. Expert consensus on the use of antibacterial drugs beyond the instructions[ J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2015, 38(6): 410-444.中国医药教育协会感染疾病专业委员会, 中华结核和呼吸杂志编辑委员会, 中国药学会药物临床评价研究专业委员会. 抗菌药物超说明书用法专家共识[ J]. 中华结核和呼吸杂志, 2015, 38(6): 410-444.
Infectious Diseases Society of China, Chinese Journal of Tuberculosis and Respiratory Diseases, Drug Clinical Evaluation Research Committee of Chinese Pharmaceutical Association. Expert consensus on the use of antibacterial drugs beyond the instructions[ J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2015, 38(6): 410-444.
3、孟敏, 王平, 兰慧, 等. 中国儿童指南共识类文章中超说明书用药分析[ J]. 中华儿科杂志, 2022, 60(3): 215-220.
MENG Min, WANG Ping, LAN Hui, et al. Analysis on off-label use of drugs in pediatric guidelines and consensus published by Chinese authors[ J]. Chinese Journal of Pediatrics, 2022, 60(3): 215-220.孟敏, 王平, 兰慧, 等. 中国儿童指南共识类文章中超说明书用药分析[ J]. 中华儿科杂志, 2022, 60(3): 215-220.
MENG Min, WANG Ping, LAN Hui, et al. Analysis on off-label use of drugs in pediatric guidelines and consensus published by Chinese authors[ J]. Chinese Journal of Pediatrics, 2022, 60(3): 215-220.
4、广东省药学会. 超药品说明书用药目录(2022年版新增用法)[ J]. 今日药学, 2022, 32(6): 401-408.
Guangdong Pharmaceutical Association. The catalogue of off-label usage (the new usage of 2022)[ J]. Pharmacy Today, 2022, 32(6): 401-408.广东省药学会. 超药品说明书用药目录(2022年版新增用法)[ J]. 今日药学, 2022, 32(6): 401-408.
Guangdong Pharmaceutical Association. The catalogue of off-label usage (the new usage of 2022)[ J]. Pharmacy Today, 2022, 32(6): 401-408.
5、山东省药学会循证药学专业委员会. 山东省超药品说明书用药专家共识(2021年版)[ J]. 临床药物治疗杂志, 2021, 19(6): 9-40.
Evidence-Based Pharmacy Specialties of Shandong Pharmaceutical Association. Expert consensus on off-label drug use of Shandong province (2021th)[ J]. Clinical Medication Journal, 2021, 19(6): 9-40.山东省药学会循证药学专业委员会. 山东省超药品说明书用药专家共识(2021年版)[ J]. 临床药物治疗杂志, 2021, 19(6): 9-40.
Evidence-Based Pharmacy Specialties of Shandong Pharmaceutical Association. Expert consensus on off-label drug use of Shandong province (2021th)[ J]. Clinical Medication Journal, 2021, 19(6): 9-40.
6、美国眼科学会. 眼科临床指南[M]. 赵家良编译. 北京: 人民卫生出版社, 2018: 467.
American Academy of Ophthalmology. Clinical guidelines for ophthalmology[M]. Translated by ZHAO Jialiang. Beijing: People’s Health Publishing House, 2018: 467.美国眼科学会. 眼科临床指南[M]. 赵家良编译. 北京: 人民卫生出版社, 2018: 467.
American Academy of Ophthalmology. Clinical guidelines for ophthalmology[M]. Translated by ZHAO Jialiang. Beijing: People’s Health Publishing House, 2018: 467.
7、邵毅, 周琼. 糖尿病视网膜病变诊治规范—2018年美国眼科学会临床指南解读[ J]. 眼科新进展2019, 39(6): 501-506.
SHAO Yi, ZHOU Qiong. Interpretation of clinical guidelines for diabetic retinopathy of the American Academy of Ophthalmology 2018[ J]. Recent Advances in Ophthalmology, 2019, 39(6): 501-506.邵毅, 周琼. 糖尿病视网膜病变诊治规范—2018年美国眼科学会临床指南解读[ J]. 眼科新进展2019, 39(6): 501-506.
SHAO Yi, ZHOU Qiong. Interpretation of clinical guidelines for diabetic retinopathy of the American Academy of Ophthalmology 2018[ J]. Recent Advances in Ophthalmology, 2019, 39(6): 501-506.
8、中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[ J]. 中华眼科杂志2014, 50(11): 851-865.
Fundus Diseases Group of Chinese Ophthalmological Society. Clinical diagnosis and treatment guidelines for diabetes retinopathy in China (2014)[ J]. Chinese Journal of Ophthalmology, 2014, 50(11): 851-865.中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[ J]. 中华眼科杂志2014, 50(11): 851-865.
Fundus Diseases Group of Chinese Ophthalmological Society. Clinical diagnosis and treatment guidelines for diabetes retinopathy in China (2014)[ J]. Chinese Journal of Ophthalmology, 2014, 50(11): 851-865.
9、中华医学会眼科学会白内障与人工晶状体学组. 我国白内障摘除手术后感染性眼内炎防治专家共识(2017年)[ J]. 中华眼科杂志2017, 53(11): 810-813.
Cataracts and Intraocular Lens Group of Chinese Ophthalmological Society. Consensus of experts on prevention and treatment of infectious endophthalmitis after cataract extraction in China (2017)[ J]. Chinese Journal of Ophthalmology, 2017, 53(11): 810-813.中华医学会眼科学会白内障与人工晶状体学组. 我国白内障摘除手术后感染性眼内炎防治专家共识(2017年)[ J]. 中华眼科杂志2017, 53(11): 810-813.
Cataracts and Intraocular Lens Group of Chinese Ophthalmological Society. Consensus of experts on prevention and treatment of infectious endophthalmitis after cataract extraction in China (2017)[ J]. Chinese Journal of Ophthalmology, 2017, 53(11): 810-813.
10、中华医学会眼科学分会白内障与人工晶状体学组. 我国白内障术后急性细菌性眼内炎治疗专家共识(2010年)[ J]. 中华眼科杂志, 2010, 46(8): 764-766.
Cataracts and Intraocular Lens Group of Chinese Ophthalmological Society. Expert consensus on the treatment of acute bacterial endophthalmitis after cataract surgery in China (2010)[ J]. Chinese Journal of Ophthalmology, 2010, 46(8): 764-766.中华医学会眼科学分会白内障与人工晶状体学组. 我国白内障术后急性细菌性眼内炎治疗专家共识(2010年)[ J]. 中华眼科杂志, 2010, 46(8): 764-766.
Cataracts and Intraocular Lens Group of Chinese Ophthalmological Society. Expert consensus on the treatment of acute bacterial endophthalmitis after cataract surgery in China (2010)[ J]. Chinese Journal of Ophthalmology, 2010, 46(8): 764-766.
11、北京协和医院. 眼科诊疗常规(第2版)[M]. 北京: 人民卫生出版社, 2013: 194.
Peking Union Medical College Hospital. Ophthalmic diagnosis and treatment routine (2nd edition)[M]. Beijing: People’s Health Publishing House, 2013: 194.北京协和医院. 眼科诊疗常规(第2版)[M]. 北京: 人民卫生出版社, 2013: 194.
Peking Union Medical College Hospital. Ophthalmic diagnosis and treatment routine (2nd edition)[M]. Beijing: People’s Health Publishing House, 2013: 194.
12、中华医学会眼科学分会角膜病学组. 感染性角膜病临床诊疗专家共识(2011年)[ J]. 中华眼科杂志, 2012, 48(1): 72-75.
Coronaropathy Group of Chinese Ophthalmological Society. Expert consensus on clinical diagnosis and treatment of infectious keratopathy (2011)[ J]. Chinese Journal of Ophthalmology, 2012, 48(1): 72-75.中华医学会眼科学分会角膜病学组. 感染性角膜病临床诊疗专家共识(2011年)[ J]. 中华眼科杂志, 2012, 48(1): 72-75.
Coronaropathy Group of Chinese Ophthalmological Society. Expert consensus on clinical diagnosis and treatment of infectious keratopathy (2011)[ J]. Chinese Journal of Ophthalmology, 2012, 48(1): 72-75.
13、Barry P, Cordovés L, Gardner S. ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: data, dilemmas and conclusions[EB/OL]. 2013 (2022-03-05). https://www. escrs.org/media/uljgvpn1/english_2018_updated.pdf.Barry P, Cordovés L, Gardner S. ESCRS guidelines for prevention
and treatment of endophthalmitis following cataract surgery: data,
dilemmas and conclusions[EB/OL]. 2013 (2022-03-05). https://www.
escrs.org/media/uljgvpn1/english_2018_updated.pdf.
14、Gilbert DN, Chambers HF, Saag MS, 等. 热病:桑福德抗微生物治疗指南(新译48版)[M]. 范洪伟主译. 北京: 中国协和医科大学出版社, 2020: 16.
Gilbert DN, Chambers HF, Saag MS, et al. Fever: Sanford antimicrobial therapy guidelines (new translation 48 edition)[M]. Translated by FAN Hongwei. Beijing: China Union Medical University Press, 2020: 16.Gilbert DN, Chambers HF, Saag MS, 等. 热病:桑福德抗微生物治疗指南(新译48版)[M]. 范洪伟主译. 北京: 中国协和医科大学出版社, 2020: 16.
Gilbert DN, Chambers HF, Saag MS, et al. Fever: Sanford antimicrobial therapy guidelines (new translation 48 edition)[M]. Translated by FAN Hongwei. Beijing: China Union Medical University Press, 2020: 16.
15、国家卫生计生委医政医管局, 国家卫生计生委合理用药专家委员会. 国家抗微生物治疗指南[M]. 第2版. 北京: 人民卫生出版社, 2017: 70.
Medical Administration of National Health Commission of the People’s Republic of China, Expert Committee on Rational Drug Use of National Health Commission of the People’s Republic of China. National antimicrobial therapy guidelines[M]. 2nd ed. Beijing: People’s Health Publishing House, 2017: 70.国家卫生计生委医政医管局, 国家卫生计生委合理用药专家委员会. 国家抗微生物治疗指南[M]. 第2版. 北京: 人民卫生出版社, 2017: 70.
Medical Administration of National Health Commission of the People’s Republic of China, Expert Committee on Rational Drug Use of National Health Commission of the People’s Republic of China. National antimicrobial therapy guidelines[M]. 2nd ed. Beijing: People’s Health Publishing House, 2017: 70.
16、汤淳, 陈俭华, 汪凯林. 婴幼儿泪道阻塞合并慢性泪囊炎的激光治疗[ J]. 眼外伤职业眼病杂志, 2007, 29(4): 286-287.
TANG Chun, CHEN Jianhua, WANG Kailin. Treatment of laser on lacrimal duct obstruction combining chronic dacryocystitis of infant and younger[ J]. Chinese Journal of Ocular Trauma and Occupational Eye Disease, 2007, 29(4): 286-287.汤淳, 陈俭华, 汪凯林. 婴幼儿泪道阻塞合并慢性泪囊炎的激光治疗[ J]. 眼外伤职业眼病杂志, 2007, 29(4): 286-287.
TANG Chun, CHEN Jianhua, WANG Kailin. Treatment of laser on lacrimal duct obstruction combining chronic dacryocystitis of infant and younger[ J]. Chinese Journal of Ocular Trauma and Occupational Eye Disease, 2007, 29(4): 286-287.
17、王冰, 王传富, 朱学军. 甲硝唑治疗棘阿米巴角膜炎的临床观
察[ J]. 中国实用眼科杂志, 2006, 24(2): 222-223.
WANG Bing, WANG Chuanfu, ZHU Xuejun. Clinical observation of
metronidazole in the treatment of acanthamoeba keratitis[ J]. Chinese
Journal of Practical Ophthalmology, 2006, 24(2): 222-223.王冰, 王传富, 朱学军. 甲硝唑治疗棘阿米巴角膜炎的临床观
察[ J]. 中国实用眼科杂志, 2006, 24(2): 222-223.
WANG Bing, WANG Chuanfu, ZHU Xuejun. Clinical observation of
metronidazole in the treatment of acanthamoeba keratitis[ J]. Chinese
Journal of Practical Ophthalmology, 2006, 24(2): 222-223.
18、American Academy of Ophthalmology. Preferred practice pattern
guidelines, bacterial keratitis—limited revision[EB/OL]. 2011
(2022-03-05). http://one.aao.org/CE/PracticeGuidelines/PPP.aspx.American Academy of Ophthalmology. Preferred practice pattern
guidelines, bacterial keratitis—limited revision[EB/OL]. 2011
(2022-03-05). http://one.aao.org/CE/PracticeGuidelines/PPP.aspx.
19、Sweetman SC. 马丁代尔药物大典[M]. 第37版. 李大魁等译. 北京:
化学工业出版社, 2014: 269, 1474.
Sweetman SC. Martin Dale’s pharmacopoeia[M]. 37th ed. Translated
by LI Dakui. Beijing: Chemical Industry Press, 2014: 269, 1474.Sweetman SC. 马丁代尔药物大典[M]. 第37版. 李大魁等译. 北京:
化学工业出版社, 2014: 269, 1474.
Sweetman SC. Martin Dale’s pharmacopoeia[M]. 37th ed. Translated
by LI Dakui. Beijing: Chemical Industry Press, 2014: 269, 1474.
20、Austin A, Lietman T, Rose-Nussbaumer J. Update on the management
of infectious keratitis[ J]. Ophthalmology, 2017, 124(11): 1678-1689.Austin A, Lietman T, Rose-Nussbaumer J. Update on the management
of infectious keratitis[ J]. Ophthalmology, 2017, 124(11): 1678-1689.
21、Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline
for the management of candidiasis: 2016 update by the Infectious
Diseases Society of America[ J]. Clin Infect Dis, 2016, 62(4): e1-50.Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline
for the management of candidiasis: 2016 update by the Infectious
Diseases Society of America[ J]. Clin Infect Dis, 2016, 62(4): e1-50.
22、卫生部合理用药专家委员会. 中国医师药师临床用药指南[M].
重庆: 重庆出版社, 2014.
Expert Committee on R ational Drug Use of National Health
Commission of the People’s Republic of China. Clinical medication
guidelines for Chinese doctors and pharmacists[M]. Chongqing:
Chongqing Publishing House, 2014.卫生部合理用药专家委员会. 中国医师药师临床用药指南[M].
重庆: 重庆出版社, 2014.
Expert Committee on R ational Drug Use of National Health
Commission of the People’s Republic of China. Clinical medication
guidelines for Chinese doctors and pharmacists[M]. Chongqing:
Chongqing Publishing House, 2014.
23、白利广, 辛鑫. 角膜基质内注射不同浓度氟康唑治疗真菌性角
膜炎的疗效观察[ J]. 中华实验眼科杂志, 2017, 35(2): 165-169.
BAI Liguang, XIN Xin. Clinical observation of corneal stroma
injection of different concentrations of flueonazole for fungal
keratltis[ J]. Chinese Journal of Experimental Ophthalmology, 2017,
35(2): 165-169.白利广, 辛鑫. 角膜基质内注射不同浓度氟康唑治疗真菌性角
膜炎的疗效观察[ J]. 中华实验眼科杂志, 2017, 35(2): 165-169.
BAI Liguang, XIN Xin. Clinical observation of corneal stroma
injection of different concentrations of flueonazole for fungal
keratltis[ J]. Chinese Journal of Experimental Ophthalmology, 2017,
35(2): 165-169.
24、李贵刚, 王娟, 徐玲娟, 等. 0.2%氟康唑注射液前房冲洗治疗真菌
性角膜炎[ J]. 临床眼科杂志, 2013, 21(4): 341-343.
LI Guigang, WANG Juan, XU Lingjuan, et al. Efficacy of 0.2%
fluconazole anterior chamber irrigation as the treatment for fungal
keratitis[ J]. Journal of Clinical Ophthalmology, 2013, 21(4): 341-343.李贵刚, 王娟, 徐玲娟, 等. 0.2%氟康唑注射液前房冲洗治疗真菌
性角膜炎[ J]. 临床眼科杂志, 2013, 21(4): 341-343.
LI Guigang, WANG Juan, XU Lingjuan, et al. Efficacy of 0.2%
fluconazole anterior chamber irrigation as the treatment for fungal
keratitis[ J]. Journal of Clinical Ophthalmology, 2013, 21(4): 341-343.
25、郭立斌, 孙鼎, 叶俊杰. 更昔洛韦玻璃体腔注药术治疗急性视网
膜坏死[ J]. 中华眼科杂志, 2007, 43(7): 631-637.
GUO Libin, SUN Ding, YE Junjie, et al. Intravitreal injection of
ganciclovir in the treatment of acute retinal necrosis[ J]. Chinese
Journal of Ophthalmology, 2007, 43(7): 631-637.郭立斌, 孙鼎, 叶俊杰. 更昔洛韦玻璃体腔注药术治疗急性视网
膜坏死[ J]. 中华眼科杂志, 2007, 43(7): 631-637.
GUO Libin, SUN Ding, YE Junjie, et al. Intravitreal injection of
ganciclovir in the treatment of acute retinal necrosis[ J]. Chinese
Journal of Ophthalmology, 2007, 43(7): 631-637.
26、曹征, 叶锦华, 陈硕, 等. 羊膜移植联合重组干扰素a1b滴眼预
防翼状胬肉术后复发的临床观察[ J]. 中国医师杂志, 2005, S1:
59-60.
CAO Zheng, YE Jinhua, CHEN Shuo, et al. Amnion transplant
combining interferon a1b dripping eyes can prevent recurrent
pterygium excision after the operation[ J]. Journal of Chinese Physician,
2005, S1: 59-60.曹征, 叶锦华, 陈硕, 等. 羊膜移植联合重组干扰素a1b滴眼预
防翼状胬肉术后复发的临床观察[ J]. 中国医师杂志, 2005, S1:
59-60.
CAO Zheng, YE Jinhua, CHEN Shuo, et al. Amnion transplant
combining interferon a1b dripping eyes can prevent recurrent
pterygium excision after the operation[ J]. Journal of Chinese Physician,
2005, S1: 59-60.
27、The U.S. Food and Drug Administration. DEXYCU (dexamethasone
intraocular suspension)[EB/OL]. 2018 (2022-03-05). https://www.
accessdata.fda.gov/drugsatfda_docs/label/2018/208912s000lbl.pdf.The U.S. Food and Drug Administration. DEXYCU (dexamethasone
intraocular suspension)[EB/OL]. 2018 (2022-03-05). https://www.
accessdata.fda.gov/drugsatfda_docs/label/2018/208912s000lbl.pdf.
28、Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for
the management of retinal vein occlusion by the European Society of
Retina Specialists (EURETINA)[ J]. Ophthalmologica, 2019, 242(3):
123-162.Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for
the management of retinal vein occlusion by the European Society of
Retina Specialists (EURETINA)[ J]. Ophthalmologica, 2019, 242(3):
123-162.
29、张永鹏, 孙艺梦, 贾力蕴, 等. 曲安奈德联合吲哚菁绿复合染色技
术在黄斑前膜手术中应用的临床研究[ J]. 中华眼科医学杂志.
电子版, 2020, 10(6): 339-344.
ZHANG Yongpeng, SUN Yimeng, JIA Liyun, et al. The application
of double vital staining technique in macular epiretinal membrane
surgery[ J]. Chinese Journal of Ophthalmologic Medicine. Electronic
Edition, 2020, 10(6): 339-344.张永鹏, 孙艺梦, 贾力蕴, 等. 曲安奈德联合吲哚菁绿复合染色技
术在黄斑前膜手术中应用的临床研究[ J]. 中华眼科医学杂志.
电子版, 2020, 10(6): 339-344.
ZHANG Yongpeng, SUN Yimeng, JIA Liyun, et al. The application
of double vital staining technique in macular epiretinal membrane
surgery[ J]. Chinese Journal of Ophthalmologic Medicine. Electronic
Edition, 2020, 10(6): 339-344.
30、中华医学会眼科学会青光眼学组. 中国新生血管性青光眼诊疗
专家共识(2019年)[ J]. 中华眼科杂志, 2019, 55(11): 814-817.
Glaucoma Group of Chinese Ophthalmological Society. Chinese
experts’ consensus on diagnosis and treatment of neovascular glaucoma
(2019)[ J]. Chinese Journal of Ophthalmology, 2019, 55(11): 814-817.中华医学会眼科学会青光眼学组. 中国新生血管性青光眼诊疗
专家共识(2019年)[ J]. 中华眼科杂志, 2019, 55(11): 814-817.
Glaucoma Group of Chinese Ophthalmological Society. Chinese
experts’ consensus on diagnosis and treatment of neovascular glaucoma
(2019)[ J]. Chinese Journal of Ophthalmology, 2019, 55(11): 814-817.
31、Vural A, Perente ?, Onur ?U, et al. Efficacy of intravitreal aflibercept
monotherapy in retinopathy of prematurity evaluated by periodic
fluorescence angiography and optical coherence tomography[ J]. Int
Ophthalmol, 2019, 39(10): 2161-2169.Vural A, Perente ?, Onur ?U, et al. Efficacy of intravitreal aflibercept
monotherapy in retinopathy of prematurity evaluated by periodic
fluorescence angiography and optical coherence tomography[ J]. Int
Ophthalmol, 2019, 39(10): 2161-2169.
32、Sukgen EA, Ko?luk Y. Comparison of clinical outcomes of intravitreal
ranibizumab and aflibercept treatment for retinopathy of prematurity[ J].
Graefes Arch Clin Exp Ophthalmol, 2019, 257(1): 49-55.Sukgen EA, Ko?luk Y. Comparison of clinical outcomes of intravitreal
ranibizumab and aflibercept treatment for retinopathy of prematurity[ J].
Graefes Arch Clin Exp Ophthalmol, 2019, 257(1): 49-55.
33、Vedantham V. Intravitreal aflibercept injection in Indian eyes with
retinopathy of prematurity[J]. Indian J Ophthalmol, 2019, 67(6): 884-888.Vedantham V. Intravitreal aflibercept injection in Indian eyes with
retinopathy of prematurity[J]. Indian J Ophthalmol, 2019, 67(6): 884-888.
34、中华医学会眼科学分会青光眼学组. 中国青光眼引流阀植入
手术操作专家共识(2019年2版)[ J]. 中华眼科杂志, 2019, 55(2):
93-97.
Glaucoma Group of Chinese Ophthalmological Society. Expert
consensus on the operation of glaucoma drainage valve implantation
in China (2nd edition 2019)[ J]. Chinese Journal of Ophthalmology,
2019, 55(2): 93-97.中华医学会眼科学分会青光眼学组. 中国青光眼引流阀植入
手术操作专家共识(2019年2版)[ J]. 中华眼科杂志, 2019, 55(2):
93-97.
Glaucoma Group of Chinese Ophthalmological Society. Expert
consensus on the operation of glaucoma drainage valve implantation
in China (2nd edition 2019)[ J]. Chinese Journal of Ophthalmology,
2019, 55(2): 93-97.
35、Gedde SJ, Vinod K, Wright MM, et al. Primary open-angle glaucoma
preferred practice pattern?[ J]. Ophthalmology, 2021, 128(1): P71-P150.Gedde SJ, Vinod K, Wright MM, et al. Primary open-angle glaucoma
preferred practice pattern?[ J]. Ophthalmology, 2021, 128(1): P71-P150.
36、中华医学会眼科学分会眼视光学组. 中国经上皮准分子激光
角膜切削术专家共识(2019年)[ J]. 中华眼科杂志, 2019, 55(3):
169-173.
Eye Optics Group of Chinese Ophthalmological Society. Chinese
experts’ consensus on transepithelial excimer laser keratectomy
(2019)[ J]. Chinese Journal of Ophthalmology, 2019, 55(3): 169-173.中华医学会眼科学分会眼视光学组. 中国经上皮准分子激光
角膜切削术专家共识(2019年)[ J]. 中华眼科杂志, 2019, 55(3):
169-173.
Eye Optics Group of Chinese Ophthalmological Society. Chinese
experts’ consensus on transepithelial excimer laser keratectomy
(2019)[ J]. Chinese Journal of Ophthalmology, 2019, 55(3): 169-173.
37、Green E, Wilkins M, Bunce C, et al. 5-fluorouracil for glaucoma
surgery[ J]. Cochrane Database Syst Rev, 2014(2): CD001132.Green E, Wilkins M, Bunce C, et al. 5-fluorouracil for glaucoma
surgery[ J]. Cochrane Database Syst Rev, 2014(2): CD001132.
38、国家卫生健康委办公厅. 儿童视网膜母细胞瘤诊疗规范[EB/
OL]. (2022-03-05) [2019-09-05]. http://www.nhc.gov.cn/yzygj/s359
3/201909/5f1d3329606e4cd2aa6e501603703ee4/files/d033d107ed7
c4b93af41302e2e92d2e6.pdf.
General Office of the National Health Commission of the People’s
Republic of China. Diagnostic and therapeutic specifications for
retinoblastoma in children[EB/OL]. (2022-03-05) [2019-09-05].
http://www.nhc.gov.cn/yzygj/s3593/201909/5f1d3329606e4cd2aa6
e501603703ee4/files/d033d107ed7c4b93af41302e2e92d2e6.pdf.国家卫生健康委办公厅. 儿童视网膜母细胞瘤诊疗规范[EB/
OL]. (2022-03-05) [2019-09-05]. http://www.nhc.gov.cn/yzygj/s359
3/201909/5f1d3329606e4cd2aa6e501603703ee4/files/d033d107ed7
c4b93af41302e2e92d2e6.pdf.
General Office of the National Health Commission of the People’s
Republic of China. Diagnostic and therapeutic specifications for
retinoblastoma in children[EB/OL]. (2022-03-05) [2019-09-05].
http://www.nhc.gov.cn/yzygj/s3593/201909/5f1d3329606e4cd2aa6
e501603703ee4/files/d033d107ed7c4b93af41302e2e92d2e6.pdf.
39、中华医学会眼科学分会眼整形眼眶病学组. 中国单侧眼内期视
网膜母细胞瘤诊疗专家共识(2019年)[ J]. 中华眼科杂志, 2019,
55(4): 250-254.
Ophthalmology and Orbital Diseases Group of Chinese
Ophthalmological Society. Chinese expert consensus on diagnosis and
treatment of unilateral intraocular retinoblastoma (2019)[ J]. Chinese
Journal of Ophthalmology, 2019, 55(4): 250-254.中华医学会眼科学分会眼整形眼眶病学组. 中国单侧眼内期视
网膜母细胞瘤诊疗专家共识(2019年)[ J]. 中华眼科杂志, 2019,
55(4): 250-254.
Ophthalmology and Orbital Diseases Group of Chinese
Ophthalmological Society. Chinese expert consensus on diagnosis and
treatment of unilateral intraocular retinoblastoma (2019)[ J]. Chinese
Journal of Ophthalmology, 2019, 55(4): 250-254.
40、郭利红. 高渗葡萄糖在白内障术后角膜水肿的疗效研究[ J]. 中
外女性健康研究, 2017(15):74-75.
GUO Lihong. Effect of hypertonic glucose on corneal edema after
cataract surgery[ J]. Women’s Health Research, 2017(15): 74-75.郭利红. 高渗葡萄糖在白内障术后角膜水肿的疗效研究[ J]. 中
外女性健康研究, 2017(15):74-75.
GUO Lihong. Effect of hypertonic glucose on corneal edema after
cataract surgery[ J]. Women’s Health Research, 2017(15): 74-75.
41、魏礼平. 维生素C局部注射治疗角膜炎、角膜溃疡的临床疗效
观察[ J]. 临床合理用药杂志, 2013, 6(11): 58-59.
WEI Liping. Observation on the clinical effect of local injection of
vitamin C on keratitis and corneal ulcer[ J]. Chinese Journal of Clinical
Rational Drug Use, 2013, 6(11): 58-59.魏礼平. 维生素C局部注射治疗角膜炎、角膜溃疡的临床疗效
观察[ J]. 临床合理用药杂志, 2013, 6(11): 58-59.
WEI Liping. Observation on the clinical effect of local injection of
vitamin C on keratitis and corneal ulcer[ J]. Chinese Journal of Clinical
Rational Drug Use, 2013, 6(11): 58-59.
42、Li FF, Kam KW, Zhang Y, et al. Differential effects on ocular
biometrics by 0.05%, 0.025%, and 0.01% atropine: low-concentration
atropine for myopia progression study[ J]. Ophthalmology, 2020,
127(12): 1603-1611.Li FF, Kam KW, Zhang Y, et al. Differential effects on ocular
biometrics by 0.05%, 0.025%, and 0.01% atropine: low-concentration
atropine for myopia progression study[ J]. Ophthalmology, 2020,
127(12): 1603-1611.
43、Jethani J. Efficacy of low-concentration atropine (0.01%) eye drops
for prevention of axial myopic progression in premyopes[ J]. Indian J
Ophthalmol, 2022, 70(1): 238-240.Jethani J. Efficacy of low-concentration atropine (0.01%) eye drops
for prevention of axial myopic progression in premyopes[ J]. Indian J
Ophthalmol, 2022, 70(1): 238-240.
44、冀鹏飞, 高延庆, 潘俊辉, 等. 球后注射山莨菪碱联合高压氧治疗
非动脉炎性前部缺血性视神经病变的疗效观察[ J]. 实用防盲
技术, 2017, 12(3): 96-98.
JI Pengfei, GAO Yanqing, PAN Junhui, et al. The curative effects
of hyperbaric oxygen combined with retrobulbar injection with
anisodamine on nonarteritic anterior ischemic optic neuropathy[ J].
Journal of Practical Preventing Blind, 2017, 12(3): 96-98.冀鹏飞, 高延庆, 潘俊辉, 等. 球后注射山莨菪碱联合高压氧治疗
非动脉炎性前部缺血性视神经病变的疗效观察[ J]. 实用防盲
技术, 2017, 12(3): 96-98.
JI Pengfei, GAO Yanqing, PAN Junhui, et al. The curative effects
of hyperbaric oxygen combined with retrobulbar injection with
anisodamine on nonarteritic anterior ischemic optic neuropathy[ J].
Journal of Practical Preventing Blind, 2017, 12(3): 96-98.
45、王竞, 王春芳. 弱视治疗新进展[ J]. 国际眼科杂志, 2019, 19(4):
604-608.
WANG Jing , WANG Chunfang. New progress of amblyopia
treatment[ J] International Eye Science, 2019, 19(4): 604-608.王竞, 王春芳. 弱视治疗新进展[ J]. 国际眼科杂志, 2019, 19(4):
604-608.
WANG Jing , WANG Chunfang. New progress of amblyopia
treatment[ J] International Eye Science, 2019, 19(4): 604-608.
46、陈彦婷, 李山祥, 何宏. 和血明目片联合胞磷胆碱钠对青光眼患
者的临床疗效[ J]. 中成药, 2021, 43(6): 1467-1471.
CHEN Yanting, LI Shanxiang, HE Hong. Clinical effects of hexue
mingmu tablets combined with citicoline sodium on patients with
glaucoma[ J]. Chinese Traditional Patent Medicine, 2021, 43(6):
1467-1471.陈彦婷, 李山祥, 何宏. 和血明目片联合胞磷胆碱钠对青光眼患
者的临床疗效[ J]. 中成药, 2021, 43(6): 1467-1471.
CHEN Yanting, LI Shanxiang, HE Hong. Clinical effects of hexue
mingmu tablets combined with citicoline sodium on patients with
glaucoma[ J]. Chinese Traditional Patent Medicine, 2021, 43(6):
1467-1471.
47、张鲁天, 李素霞, 张娜, 等. 他克莫司滴眼液预防高危角膜移植免
疫排斥反应的研究[ J]. 临床眼科杂志, 2017, 25(3): 193-196.
ZHANG Lutian, LI Suxia, ZHANG Na, et al. The immunosuppressive
activity of tacrolimus eye drops in high-risk corneal transplantation[ J].
Journal of Clinical Ophthalmology, 2017, 25 (3): 193-196.张鲁天, 李素霞, 张娜, 等. 他克莫司滴眼液预防高危角膜移植免
疫排斥反应的研究[ J]. 临床眼科杂志, 2017, 25(3): 193-196.
ZHANG Lutian, LI Suxia, ZHANG Na, et al. The immunosuppressive
activity of tacrolimus eye drops in high-risk corneal transplantation[ J].
Journal of Clinical Ophthalmology, 2017, 25 (3): 193-196.
48、NICE. Ciclosporin for treating dry eye disease that has not improved
despite treatment with artificial tears: technology appraisal guidance
[TA369][EB/OL]. (2022-03-05) [2015-12-16]. https://www.nice.org.
uk/guidance/ta369.NICE. Ciclosporin for treating dry eye disease that has not improved
despite treatment with artificial tears: technology appraisal guidance
[TA369][EB/OL]. (2022-03-05) [2015-12-16]. https://www.nice.org.
uk/guidance/ta369.
49、张文, 厉小梅, 徐东, 等. 原发性干燥综合征诊疗规范[ J]. 中华内
科杂志, 2020, 59(4): 269-276.
ZHANG Wen, LI Xiaomei, XU Dong, et al. Recommendations of
diagnosis and treatment of primary Sjogren’s syndrome in China[ J].
Chinese Journal of Internal Medicine, 2020, 59(4): 269-276.张文, 厉小梅, 徐东, 等. 原发性干燥综合征诊疗规范[ J]. 中华内
科杂志, 2020, 59(4): 269-276.
ZHANG Wen, LI Xiaomei, XU Dong, et al. Recommendations of
diagnosis and treatment of primary Sjogren’s syndrome in China[ J].
Chinese Journal of Internal Medicine, 2020, 59(4): 269-276.
50、Price EJ, Rauz S, Tappuni AR, et al. The British Society for Rheumatology
guideline for the management of adults with primary Sj?gren’s
Syndrome[ J]. Rheumatology (Oxford), 2017, 56(10): 1643-1647.Price EJ, Rauz S, Tappuni AR, et al. The British Society for Rheumatology
guideline for the management of adults with primary Sj?gren’s
Syndrome[ J]. Rheumatology (Oxford), 2017, 56(10): 1643-1647.
51、中国免疫学会神经免疫分会. 中国视神经脊髓炎谱系疾病诊断与治疗指南(2021版)[ J]. 中国神经免疫学和神经病学杂志, 2021, 28(6): 423-436.
Neuroimmunology Branch of Chinese Society for Immunology. Chinese guidelines for diagnosis and treatment of optic neuromyelitis pedigree diseases (2021 edition)[ J]. Chinese Journal of Neuroimmunology and Neurology, 2021, 28(6): 423-436.中国免疫学会神经免疫分会. 中国视神经脊髓炎谱系疾病诊断与治疗指南(2021版)[ J]. 中国神经免疫学和神经病学杂志, 2021, 28(6): 423-436.
Neuroimmunology Branch of Chinese Society for Immunology. Chinese guidelines for diagnosis and treatment of optic neuromyelitis pedigree diseases (2021 edition)[ J]. Chinese Journal of Neuroimmunology and Neurology, 2021, 28(6): 423-436.
52、赵堪兴, 杨培增. 眼科学[M]. 第9版. 北京: 人民卫生出版社, 2018: 111.
ZHAO Kanxing, YANG Peizeng. Ophthalmology[M]. 9th ed. Beijing: People’s Medical Publishing House, 2018: 111.赵堪兴, 杨培增. 眼科学[M]. 第9版. 北京: 人民卫生出版社, 2018: 111.
ZHAO Kanxing, YANG Peizeng. Ophthalmology[M]. 9th ed. Beijing: People’s Medical Publishing House, 2018: 111.
53、王颖, 龙文文, 方平飞, 等. 头孢菌素类抗生素在输液中的配伍稳定性[ J]. 中南药学, 2012, 10(10): 798-800.
WANG Ying, LONG Wenwen, FANG Pingfei, et al. Compatibility stability of cephalosporins in infusion[ J]. Central South Pharmacy, 2012, 10(10): 798-800.王颖, 龙文文, 方平飞, 等. 头孢菌素类抗生素在输液中的配伍稳定性[ J]. 中南药学, 2012, 10(10): 798-800.
WANG Ying, LONG Wenwen, FANG Pingfei, et al. Compatibility stability of cephalosporins in infusion[ J]. Central South Pharmacy, 2012, 10(10): 798-800.
54、宋昊刚, 崔浩. 血-眼屏障的作用及意义(综述)[ J]. 伤残医学杂志, 2005, 13(1): 62-64.
SONG Haogang, CUI Hao. Role and significance of blood eye barrier (review)[ J]. Medical Journal of Trauma and Disability, 2005, 13(1): 62-64.宋昊刚, 崔浩. 血-眼屏障的作用及意义(综述)[ J]. 伤残医学杂志, 2005, 13(1): 62-64.
SONG Haogang, CUI Hao. Role and significance of blood eye barrier (review)[ J]. Medical Journal of Trauma and Disability, 2005, 13(1): 62-64.
55、洪晶. 关注我国眼部细菌种类分布及其耐药性的变化趋势[ J]. 中华眼科杂志, 2021, 57(10): 721-723.
HONG Jing. The trend of eye bacterial species distribution and drug resistance in China[ J]. Chinese Journal of Ophthalmology, 2021, 57(10): 721-723.洪晶. 关注我国眼部细菌种类分布及其耐药性的变化趋势[ J]. 中华眼科杂志, 2021, 57(10): 721-723.
HONG Jing. The trend of eye bacterial species distribution and drug resistance in China[ J]. Chinese Journal of Ophthalmology, 2021, 57(10): 721-723.
56、Miller D. Update on the epidemiology and antibiotic resistance of ocular infections[ J]. Middle East Afr J Ophthalmol, 2017, 24(1): 30-42.Miller D. Update on the epidemiology and antibiotic resistance of ocular infections[ J]. Middle East Afr J Ophthalmol, 2017, 24(1): 30-42.
57、抗菌药物临床应用指导原则修订工作组. 抗菌药物临床应用指导原则:2015年版[M]. 北京: 人民卫生出版社, 2015: 27-28.
Group on Revision of Guiding Principles for Clinical Application of Antibiotics. Guiding principles for clinical application of antibiotics: 2015 edition[M]. Beijing: People’s Health Publishing House, 2015: 27-28.抗菌药物临床应用指导原则修订工作组. 抗菌药物临床应用指导原则:2015年版[M]. 北京: 人民卫生出版社, 2015: 27-28.
Group on Revision of Guiding Principles for Clinical Application of Antibiotics. Guiding principles for clinical application of antibiotics: 2015 edition[M]. Beijing: People’s Health Publishing House, 2015: 27-28.
58、马宁, 焦万秋, 钱丽敏. 增殖性糖尿病视网膜病变术前应用雷珠单抗及曲安奈德疗效对比分析[ J]. 世界最新医学信息文摘, 2019, 19(84): 143-144.
MA Ning, JIAO Wanqiu, QIAN Limin. Comparative analysis of the therapeutic effects of ranizumab and triamcinolone acetonide on proliferative diabetes retinopathy[ J]. World Latest Medicine Information, 2019, 19(84): 143-144.马宁, 焦万秋, 钱丽敏. 增殖性糖尿病视网膜病变术前应用雷珠单抗及曲安奈德疗效对比分析[ J]. 世界最新医学信息文摘, 2019, 19(84): 143-144.
MA Ning, JIAO Wanqiu, QIAN Limin. Comparative analysis of the therapeutic effects of ranizumab and triamcinolone acetonide on proliferative diabetes retinopathy[ J]. World Latest Medicine Information, 2019, 19(84): 143-144.
59、方莹. 曲安奈德眶周注射治疗甲状腺相关眼病的临床疗效分析[ J]. 医药论坛杂志, 2020, 41(2): 63-67.
FANG Ying. Triamcinolone acetonide peri-orbit clinical curative effect analysis of periocular injection in treatment of thyroid related ophthalmopathy[ J]. Journal of Medical Forum, 2020, 41(2): 63-67.方莹. 曲安奈德眶周注射治疗甲状腺相关眼病的临床疗效分析[ J]. 医药论坛杂志, 2020, 41(2): 63-67.
FANG Ying. Triamcinolone acetonide peri-orbit clinical curative effect analysis of periocular injection in treatment of thyroid related ophthalmopathy[ J]. Journal of Medical Forum, 2020, 41(2): 63-67.
60、高宗宝, 严静, 廖杨. 翼状胬肉切除自体角膜缘干细胞移植联合丝裂霉素C治疗翼状胬肉的效果[ J]. 中国医药导报, 2020, 17(21): 129-132.
GAO Zongbao, YAN Jing, LIAO Yang. Effect of pterygium excision autologous limbal stem cell transplantation combined with mitomycin C in the treatment of pterygium[ J]. China Medical Herald, 2020, 17(21): 129-132.高宗宝, 严静, 廖杨. 翼状胬肉切除自体角膜缘干细胞移植联合丝裂霉素C治疗翼状胬肉的效果[ J]. 中国医药导报, 2020, 17(21): 129-132.
GAO Zongbao, YAN Jing, LIAO Yang. Effect of pterygium excision autologous limbal stem cell transplantation combined with mitomycin C in the treatment of pterygium[ J]. China Medical Herald, 2020, 17(21): 129-132.
61、张园, 柯毅. 翼状胬肉手术切除加用丝裂霉素C(MMC)抑制术后复发的比较研究[ J]. 现代医院, 2012, 12(10): 44-45.
ZHANG Yuan, KE Yi. The compare research of pterygium resection add mitomycin C for restraining relapse after operation[ J]. Modern Hospital, 2021, 12(10): 44-45.张园, 柯毅. 翼状胬肉手术切除加用丝裂霉素C(MMC)抑制术后复发的比较研究[ J]. 现代医院, 2012, 12(10): 44-45.
ZHANG Yuan, KE Yi. The compare research of pterygium resection add mitomycin C for restraining relapse after operation[ J]. Modern Hospital, 2021, 12(10): 44-45.
62、Pharmaceuticals and Medical Devices Agency. LUCENTIS? solution for intravitreal injection 10 mg/mL[EB/OL]. 2019 (2022-03-05). https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/300242_1319403A1036_1_08Pharmaceuticals and Medical Devices Agency. LUCENTIS? solution for intravitreal injection 10 mg/mL[EB/OL]. 2019 (2022-03-05). https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/300242_1319403A1036_1_08
63、The U.S. Food and Drug Administration. ZALTRAP? (ziv-aflibercept)[EB/OL]. 2012 (2022-03-05).https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125418s000lbl.pdf.The U.S. Food and Drug Administration. ZALTRAP? (ziv-aflibercept)[EB/OL]. 2012 (2022-03-05).https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125418s000lbl.pdf.
64、European Medicines Agency. RAXONE, INN-idebenone[EB/OL]. 2022 (2022-08-04).https://www.ema.europa.eu/en/documents/product-information/raxone-epar-product-information_en.pdf.European Medicines Agency. RAXONE, INN-idebenone[EB/OL]. 2022 (2022-08-04).https://www.ema.europa.eu/en/documents/product-information/raxone-epar-product-information_en.pdf.